** U.S.-listed shares of China-based energy firm BIMI.O
rise ~30% to $6.45 - an over three-month high
** Co announces it will buy Chinese medical distributor
Chongqing Guanzan Technology Co Ltd through BIMI's wholly-owned
subsidiary Beijing Xin Rong Xin Industrial Development Co Ltd
** Under the deal, BIMI's subsidiary will purchase all
shares of Chongqing Guanzan for cash and stock deal of about
$14.3 mln urn:newsml:reuters.com:*:nGNX13LhkB
** Transaction expected to close in April 2020
** Co among best performers across all U.S. exchanges
** Stock had fallen ~79% in 2019, after three straight years
of gains
(Reporting by Abhishek Manikandan in Bengaluru)
((Abhishek.Manikandan@thomsonreuters.com))